About this trial
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.
Eligibility criteria
Qualifiers
Age >= 18 years
Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer [BC], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ [LCIS], or prior chest wall radiation)
Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)
Able to read and understand English
Disqualifiers
Prisoners
Not able to speak and understand English
Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC
Trial design
Treatments tested in this trial
- Follow-Up
- Physical Examination
- Questionnaire Administration
Treatment groups
Locations
1Sponsors and collaborators
Ohio State University Comprehensive Cancer Center
Lead sponsor